New eMed CEO Linda Yaccarino. Photo courtesy of eMed Population Health.

eMed Population Health announced it has appointed Linda Yaccarino as its new CEO. The former X (Twitter) CEO brings experience in leading fundamental shifts paired with transformative viewpoints.

With eMed expanding its service outreach on national and global scales aiming to accommodate its government partnerships, the company says that Yaccarino’s experience will be critical in assisting the development of peptide population health management programs. With Yaccarino’s arrival viewed as a rare opportunity to onboard an established and dynamic CEO, eMed’s board of directors all agreed the opportunity was too good to pass up.

New outlooks

eMed believes that Yaccarino has displayed the ability to construct transformative relationships while simultaneously being able to navigate complex markets. All these characteristics are cited by the company as reflecting Yaccarino’s ability to bring positive change. Board members view her as someone who can deliver on accelerating the revolution of chronic care, as well as position eMed as the definitive global leader in population health solutions.

Yaccarino’s presence and negotiation skills accompany her track record of initiating and leading transformative change while expanding company reach. The hiring of Yaccarino also aligns with eMed’s mission to provide safe, effective, and sustainable chronic care access in an all-in-one, digital first experience.

Leading by example

Before Yaccarino held her role as CEO at X, she served as chairman of global advertising and partnerships at NBCUniversal. In this role, Yaccarino oversaw all facets of partnerships, advertising, and strategic initiatives, while assisting the company introduce its global cross-sell platform which has transformed into an industry standard. Her time at NBCUniversal highlights her resume of assisting numerous organizations to traverse competitive and complex industries while also producing positive and sustainable positions.

Yaccarino spoke on her opportunity to lead eMed saying, "The healthcare industry has been disrupted by technology, but not yet completely transformed by it. There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before. To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry. We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms."¹

The Penn State University alum is expected to improve eMed’s population health program which is being adopted on a global scale, aiming to provide safe, structured, and results-driven access to life altering therapies. Recognized as a top 10 person in transforming advertising, eMed expects Yaccarino to improve and expand eMed’s national and global presence in population health.

Sources

1. eMed® Population Health Announces Appointment of Former X (Twitter) CEO Linda Yaccarino as new Chief Executive Officer eMed August 5, 2025 https://www.prnewswire.com/news-releases/emed-population-health-announces-appointment-of-former-x-twitter-ceo-linda-yaccarino-as-new-chief-executive-officer-302521918.html